JPRN-UMIN000044482尚未招募未知
Evaluation test of composition 210515 for oral cavity - Evaluation test for oral cavity
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 69years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •-Subjects with systemic illness. -Subjects with a disease in the oral cavity and are consulting the medical institution. -Subjects with periodontal disease is treated. -Subjects with the orthodontic therapy. -Subjects with mobile tooth. -Subjects with an implant. -Subjects who have regular dental checkups at least three times a year. -Subjects who have been prescribed antibiotics for swollen gingival within a year. -The pregnant and subjects who hope to get pregnant during the exam period. -Subjects who are taking prescription medicine (except for anti-hay fever). -Subjects from outside the company who work in an advertising agency, an investigation, consultancy, mass communication, and the manufacturing industry of health food, cosmetics, toiletries, a sanitary items, and a distributive trade. -Subjects who participate in the other examinations. -Subjects who had health problems (fever, cold-like symptom, abnormal taste or smell, etc.) within 2 weeks prior to the test, or subjects who had a family member living with them who showed abnormalities. -Subjects who had close contact with COVID-19 infected individuals within 2 weeks prior to the study. -Subjects who are confirmed positive in the COVID-19 antigen test on the day of measurement. -Subjects deemed inappropriate to participate in this study by the principle investigator.
研究者
相似试验
尚未招募
不适用
Evaluation test for oral cavityHealthy adultsJPRN-UMIN000047535Kao Corporation60
已完成
不适用
The efficacy test of 19220, composite for oral cavityhealthy adultsJPRN-UMIN000036288Kao Corporation10
已完成
不适用
The efficacy test of 17413, composite for oral cavityperiodontal diseaseJPRN-UMIN000028104Kao Corporation44
已完成
不适用
Efficacy test for oral cavityhealthy adultsJPRN-UMIN000037517Kao Corporation50
已完成
不适用
Oral Fluid Sars-CoV-2 Ab Rapid testCTRI/2020/06/025674Diabetes Research Society150
